Target
Bromodomain-containing protein 4 [42-168]
Ligand
BDBM318481
Substrate
n/a
Meas. Tech.
AlphaScreen Assay A1
IC50
<100±n/a nM
Citation
 Combs, APSparks, RBMaduskuie, Jr., TPRodgers, JD Tricyclic heterocycles as BET protein inhibitors US Patent  US10464947 Publication Date 11/5/2019 
Target
Name:
Bromodomain-containing protein 4 [42-168]
Synonyms:
BRD4 | BRD4 BD1 (aa 42-168) | BRD4_HUMAN | Bromodomain-containing protein 4 Bromo Domain 1 | HUNK1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
15054.68
Organism:
Homo sapiens (Human)
Description:
O60885[42-168]
Residue:
127
Sequence:
STNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE
  
Inhibitor
Name:
BDBM318481
Synonyms:
7-(3,5-Dimethylisoxazol-4-yl)-N-ethyl-4-phenyl-4,5-dihydroimidazo[1,5,4-de][1,4]benzoxazin-2-amine | US10464947, Example 27 | US11498926, Example 27 | US9624241, Example 27
Type:
Small organic molecule
Emp. Form.:
C22H22N4O2
Mol. Mass.:
374.4357
SMILES:
CCNc1nc2ccc(-c3c(C)noc3C)c3OCC(c4ccccc4)n1c23 |(4.83,3.44,;4.06,2.1,;2.52,2.1,;1.75,.77,;2.88,-.77,;1.54,-1.54,;1.54,-3.08,;.21,-3.85,;-1.13,-3.08,;-2.46,-3.85,;-2.46,-5.39,;-1.13,-6.16,;-3.92,-5.87,;-4.83,-4.62,;-3.92,-3.37,;-4.69,-2.04,;-1.13,-1.54,;-2.46,-.77,;-2.46,.77,;-1.13,1.54,;-1.13,3.08,;.21,3.85,;.21,5.39,;-1.13,6.16,;-2.46,5.39,;-2.46,3.85,;.21,.77,;.21,-.77,)|
Structure:
Search PDB for entries with ligand similarity: